Research Progress and Perspectives of Antibody-drug Conjugates Targeting Trophoblast Cell Surface Antigen-2 in Advanced Non-small Cell Lung Cancer.
Non-small cell lung cancer (NSCLC) remains a significant global health burden, and there is an urgent need for new treatment options. Trophoblast cell surface antigen-2 (TROP-2), a target closely associated with NSCLC prognosis, has become a research hotspot in recent years. Notably, TROP-2-targeted...
| Publicado en: | Chinese Journal of Lung Cancer Vol. 27; no. 10; pp. 763 - 777 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
Chinese Journal of Lung Cancer
Oct2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |